Light plays a significant role in microalgae cultivation, significantly influencing critical parameters, including biomass production, pigment content, and the accumulation of metabolic compounds. This study was intricately designed to optimize light intensities, explicitly targeting enhancing growth, pigmentation, and antioxidative properties in the green microalga, Scenedesmus falcatus (KU.B1). Additionally, the study delved into the photosynthetic efficiency in light responses of S. falcatus. The cultivation of S. falcatus was conducted in TRIS-acetate-phosphate medium (TAP medium) under different light intensities of 100, 500, and 1000μmol photons m⁻²s⁻¹ within a photoperiodic cycle of 12h of light and 12h of dark. Results indicated a gradual increase in the growth of S. falcatus under high light conditions at 1000μmol photons m⁻²s⁻¹, reaching a maximum optical density of 1.330.03 and a total chlorophyll content of 22.670.2μg/ml at 120h. Conversely, a slower growth rate was observed under low light at 100μmol photons m⁻²s⁻¹. However, noteworthy reductions in the maximum quantum yield (Fv/Fm) and actual quantum yield (Y(II)) were observed under 1000μmol photons m⁻²s⁻¹, reflecting a decline in algal photosynthetic efficiency. Interestingly, these changes under 1000μmol photons m⁻²s⁻¹ were concurrent with a significant accumulation of a high amount of beta-carotene (919.8326.33mg/g sample), lutein (34.560.19mg/g sample), and canthaxanthin (24.000.38mg/g sample) within algal cells. Nevertheless, it was noted that antioxidant activities and levels of total phenolic compounds (TPCs) decreased under high light at 1000μmol photons m⁻²s⁻¹, with IC₅₀ of DPPH assay recorded at 218.004.24 and TPC at 230.8386.75mg of GAE/g. The findings suggested that the elevated light intensity at 1000μmol photons m⁻²s⁻¹ enhanced the growth and facilitated the accumulation of valuable carotenoid pigment in S. falcatus, presenting potential applications in the functional food and carotenoid industry.

Microalgae represent promising biotechnological platforms for bioactive compound production with pharmaceutical applications. This study investigated the phytochemical composition and biological activities of lipid extracts from three Chlorella species to evaluate their potential as antioxidant and antidiabetic sources. Lipid extraction using chloroform–methanol (2:1) followed by GC–MS analysis revealed distinct compound distributions: 29 compounds in C. ellipsoidea, 33 in C. sorokiniana, and 19 in C. vulgaris. Major bioactive compounds included 2-hexanol, 1,3,6-heptatriene, 4-(2,3-dimethyl-2-cyclopenten-1-yl)-4-methylpentanal, n-hexadecanoic acid, and octadecanoic acid. Biological activity screening encompassed antioxidant assessment through DPPH• and •NO radical scavenging assays and FRAP analysis, while antidiabetic potential was evaluated using α-glucosidase and α-amylase inhibition assays. C. sorokiniana exhibited superior bioactivity with the highest antioxidant capacity (DPPH• IC₅₀ = 329.03 ± 4.30 µg/mL; •NO IC₅₀ = 435.53 ± 10.20 µg/mL; FRAP = 94.74 ± 5.72 mg TE/g) and strongest enzyme inhibition (α-glucosidase IC₅₀ = 752.75 ± 57.95 µg/mL; α-amylase IC₅₀ = 3458.50 ± 104.01 µg/mL). This is the first report on C. sorokiniana strain KU.B2′s biological properties and phytochemical profile. These findings establish C. sorokiniana as a valuable biotechnological platform for pharmaceutical bioactive compound development.

Microalgae are a potentially valuable source in the food, pharmaceutical and nutraceutical sectors. While biological activities surveys have investigated the pharmaceutical properties of a few microalgae species, there are not many reports covering biological activity studies. This study was carried out to identify the metabolites by gas chromatography-mass spectrometry and evaluate the anti-oxidant, anti-diabetic properties of green algae extracts, Chlorella sorokiniana (KU.B2) and Scenedesmus falcatus (KU.B1). A total of 51 different chemical constituents were detected and tentatively identified. The primary compounds in both microalgae extracts included (R)-2-hexanol (38.67% in C. sorokiniana and 23.53% in S. falcatus), n-hexadecanoic acid (13.58% in C. sorokiniana and 18.94% in S. falcatus) and octadecanoic acid (22.30% in C. sorokiniana and 32.67% in S. falcatus). According to the profiling results, the C. sorokiniana extract exhibited greater anti-oxidant activity, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging (IC50 = 480.30 ±?14.85 µg ml-1), nitric oxide (NO) radical scavenging (562.73 ±?3.52 µg mL-1) and ferric reducing anti-oxidant power (FRAP) of 58.51 ± 2.42 mgTE g-1. Comparatively, the C. sorokiniana extract had higher contents of alpha-glucosidase and alpha-amylase (IC50 = 491.22 ± 78.41 and 2,817.00 ±143.04 µg mL-1, respectively) than the S. falcatus extract. This first report demonstrated anti-diabetic effect of both extracts on diabetic enzymes. The results confirm microalgae's anti-oxidant and anti-diabetic properties and suggest their potential benefits in cosmeceutical, nutraceutical and pharmaceutical applications.